Schedule 13D ownership disclosure

Onconova Therapeutics Inc

Security class unavailable · CUSIP: 68232V306

Event date: 2018-02-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
492,707
Percent of class
2.7700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-012196
Form type
SC 13D/A
Filer
Traws Pharma, Inc.
CIK
CIK 1130598
Filed
Feb 26, 2018
Reporting period
Feb 12, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub